Patent · US Active

Combination of brimonidine and timolol for topical ophthalmic use

US8354409B2 · kind B2 · utility

5Cited by

32References

21Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

Chin-Ming Chang · Tustin, US
Gary J. Beck · Fullerton, US
Cynthia C. Pratt · Mission Viejo, US
Amy L. Batoosingh · Mission Viejo, US

Key dates

Filing date	Nov 30, 2011
Grant date	Jan 15, 2013
Priority date	—
Expiry date	Nov 30, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.